Bennett Novitch

Bennett Novitch is a Professor of Neurobiology in the School of Medicine at the University of California, Los Angeles (UCLA). His research focuses on neural development, stem cell biology, and neurodevelopmental disorders, with particular expertise in brain organoid modeling, spinal cord development, and cortical neurogenesis.

Dr. Novitch completed his BS in Biological Sciences at the University of Vermont (1991), followed by an MMSC in Medical Sciences from Harvard Medical School (1993), a PhD in Biological Chemistry from Harvard University (1998), and postdoctoral training in Biochemistry and Neurobiology at Columbia University (2002). His early work centered on molecular mechanisms of neural development, particularly the role of transcription factors like Olig2 in motor neuron specification.

Novitch's research has evolved significantly toward advanced in vitro modeling of human neural development and disease. His laboratory has pioneered the use of brain organoids to model neurodevelopmental disorders including epilepsy, intellectual disability, and Zika virus-related microcephaly. His team has made important contributions to understanding how transcription factors like Foxp1 regulate cortical development and neural progenitor maintenance, and how signaling pathways such as TGFβ and Notch modulate neural fate determination. Recent work has focused on the molecular mechanisms underlying cortical organization, spinal cord patterning, and the development of neural circuits in human brain assembloids.

Analysis of Novitch's publication record reveals a clear progression from fundamental studies of neural tube patterning and motor neuron development in model organisms toward sophisticated human stem cell-based models of brain development and disease. His work consistently bridges developmental neurobiology with translational applications, particularly in understanding and modeling neurodevelopmental disorders. The increasing focus on human brain organoids since 2015 represents a strategic shift toward clinically relevant models that can capture human-specific aspects of neural development.

Dr. Novitch maintains an active research program with multiple NIH-funded projects, including the UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (as Co-PI) and investigations into the molecular mechanisms of neurodevelopmental disorders using brain organoids (as PI). His laboratory is part of UCLA's broader neuroscience and developmental biology community, collaborating extensively with researchers studying stem cell biology, neurogenetics, and computational neuroscience.

The Novitch Lab at UCLA operates at the intersection of developmental neurobiology and translational medicine, with a growing emphasis on using human stem cell-derived models to understand and potentially treat neurodevelopmental conditions. The lab's work has significant implications for understanding the cellular and molecular basis of conditions like autism spectrum disorders, intellectual disability, and epilepsy.